Dr. Anna Maria Lavezzi, graduated in Biological Sciences and Medicine, is Associate Professor of Pathology at the Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy. She is Scientific Director of the “Lino Rossi” Research Center for the study and prevention of unexpected perinatal death and sudden infant death syndrome (SIDS), University of Milan, Italy. She is member of the International Stillbirth Alliance and has major international collaborations (as with the Center for Autonomic Medicine in Pediatrics of the Children’s Memorial Hospital, Chicago, USA; the Department of Neurosurgery and Molecular Pharmacology of the Brown University Medical School, Providence, Rhode Island, USA, and the Department of Environmental Medicine of the University of Rijeka, Croatia). She is author of many publications (over 250), mainly concerning the neuropathology of the sudden perinatal death, in international journals ad high impact factor.

Dr Mohamed Abdel-Daim is an associate professor of Pharmacology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt. He was published many manuscripts in experimental and food animals at many scientific journals related to Pharmacology, Drug Toxicology, Biochemistry, Clinical Pathology, Molecular Biology and Alternative Medicine. He is currently a member of Research Ethics Council, Academy of Scientific Research & Technology, Egypt. He has high experience in revision activities in more than 150 scientific journals.

Dr. Francesco Paolo Busardò obtained his Degree with honor in Medicine and Surgery at the University of Palermo (Italy), winning the Prize for the Best Thesis; he also got a MSc in Forensic Toxicology at the University of Glasgow (Scotland) and a PhD in Forensic Science at “Sapienza” University of Rome (Italy), where he currently works as forensic toxicologist.

He is author of more than 90 papers with I.F., with a total I.F. higher than 250 and h-index of 11.

Biography: I am a molecular genetic specialist especially in the field of human and population genetic. I am coinvestigator in Tehran Lipid and Glucose study (a cohort with 20 years old) and I am main investigator in Tehran cardiometabolic genetic study which evaluate genetic analysis for more than 15000 attendances in this cohort. I try to lead project toward personalized medicine in Iran.

Dr. Iavarone Federica is currently working as researcher in Catholic University of Sacred Heart School of Medicine. In 2010 obtained with full merit the Specialization in Clinical Biochemistry at the Medicine Faculty of the Catholic University of Sacred Heart in Rome. Her research goals are in the field of human proteomics, in particular in the identification of biomarkers in different biological fluids as saliva and urine. She has over 50 papers published in refereed journals.

Dr. Shicheng Guo received his Ph.D. degree in Fudan University in 2015. After the post-doctoral training at University of Texas Health Science Center at Houston (UT Health) and University of California, San Diego (UCSD), Dr. Guo joined Center for Precision Medicine Research at the Marshfield Clinic Research Institute. Dr. Guo made series contribution on Human PBMC methylome, Silk methylome and tissue- of-origin mapping by cell-free circulating DNA methylation. Now, He is focusing on genetic epidemiology and the diagnostic and prognostic roles of epigenetic variations in human complex disease, especially human autoimmune disease and cancer. In the Marshfield Clinic, Dr. Guo will make full use of his bioinformatics, big data analysis and text mining skills to valuable Marshfield Personalize Medicine Research Project dataset (including 20,000 Exome-chip data and comprehensive clinical and epidemiological information) and Roadmap, Blueprint, Encode project to identify disease susceptibility genes and epigenetic markers for early diagnosis or real-time prognosis surveillance.

Huangxian Ju, B.S., M.S. and Ph.D in 1986, 1989 and 1992, and lecturer, associate professor and professor in 1992, 1993 and 1999 at Nanjing University, is currently the director of State Key Laboratory of Analytical Chemistry for Life Science. He won the National Funds for National Distinguished Young Scholars in 2003 and was selected as a Changjiang Professor by Education Ministry of China in 2007 and Fellows of the International Society of Electrochemistry and the Royal Society of Chemistry in 2015. He have published 632 papers, 3 English books, 7 Chinese books with >26300 citations and h-index of 84 (Google Scholar h-index 95 with 31302 citations) up to Oct 20, 2018.

Dr. Angela Lombardi received BS from the University of Naples in 2006. She further obtained PhD from the University of Salento, Lecce, Italy in 2010. She is presently associated with the department of Chemical Sciences in the University of Naples Federico. She is a professional member of Endocrine Society, American Diabetes Association, and European Association for the Study of Diabetes. She has been recognized with awards and honors such as Doctorate Student in Biology and Biotechnology Award, European Association for the Study of Diabetes Travel Grant Award, Telethon Research Young Investigator Award and Helmsley Charitable Trust Abstract Awards in Type 1 Diabetes. She has contributed more the 150 publications, having citations around 3,417.

Dr. Olorunseun Ogunwobi obtained a medical degree from the University of Ibadan, Nigeria, a master's degree in biomedicine from the University of Hull, United Kingdom, a master's degree in clinical and translational science from the University of Florida, Gainesville, USA, and a PhD in molecular medicine from the University of East Anglia, Norwich, United Kingdom. He is the founding Director of the Hunter College Center for Cancer Health Disparities Research, Associate Professor of Biological Sciences at Hunter College of The City University of New York, and a member of faculty in the Biology and Biochemistry PhD programs at The Graduate Center of The City University of New York. Dr. Ogunwobi is a Contact Principal Investigator of the Synergistic Partnership for Enhancing Equity in Cancer Health (SPEECH) funded by a U54 grant from the National Cancer Institute. An author of 53 peer-reviewed journal articles and 2 book chapters, Dr. Ogunwobi has been issued 3 United States patents for biotechnology inventions with potential clinical applications in cancer.

Elia Ranzato is cell biologist involved in characterization of cellular and molecular responses during wound healing and tissue regeneration processes.

Michele Yip-Schneider received her PhD in Biochemistry from the University of California, Davis. Following post-doctoral training at the University of California, Los Angeles and Indiana University School of Medicine, she joined the Department of Surgery faculty at Indiana University School of Medicine in 2001. Her training in molecular biology and human disease provides the foundation and expertise to pursue current translational studies in pancreatic cancer.

Dr. R.K.Poopal, completed MSc, MPhil, PhD, Diploma, at Department of Zoology, Bharathiar University, Coimbatore, and NPDF (DST-SERB) at Bharathidasan University, Tiruchirappalli, TN, India. He serves as Scientific Researcher and Foreign Expert, Institute of Environment and Ecology, Shandong Normal University, Jinan, China, and Editorial board member for The Open Biomarkers Journal. He is also an editorial board member in four journals. He published more than 20 research articles in SCI journals. More than 15 journals have invited him as a peer reviewer. His research area is Eco-Toxicology, impact assessment of waterborne contaminants in fish. He focuses on the determination of LC50, monitoring behaviour and biomarkers responses of fish to waterborne contaminants.

Rawan Tarawneh, MD is an Assistant Professor of Neurology and leader of the Neurology Biomarker Core at the Ohio State University. She completed her neurology residency and fellowship training at Washington University in St. Louis, where she worked in the laboratory of Dr David Holtzman. Her research focuses on the use of genomics and high through-put bioinformatics for the identification of novel biomarkers to assist in diagnosis, prognosis, and novel drug discovery for neurodegenerative disorders, particularly Alzheimer’s disease. Dr Tarawneh’s research has contributed to the identification of two novel protein biomarkers of Alzheimer’s disease, visinin-like protein-1 (VILIP-1) and neurogranin, which have proven utility as measures of neuronal and synaptic injury, respectively, in Alzheimer’s disease. These biomarkers have been recognized by the Alzheimer’s Association among the most important advances in Alzheimer’s Disease biomarker research over the last decade. She is currently involved in several projects at the Ohio State University that utilize bioinformatics for novel biomarker and drug target discovery for neurodegenerative disorders.

Dr. Wei Wu is an Associate Professor and Associate Department Chair in the Department of Toxicology at Nanjing Medical University, China, where he received his Ph.D. in Toxicology in 2012. He was a guest researcher at the National Institute of Environmental Health Sciences (NIEHS) between 2017 and 2018. His research interests include epigenetic mechanisms of transgenerational effects of male infertility induced by endocrine disrupting chemicals, environmental exposure, and male reproductive health, genetic and epigenetic risk factors of male infertility and abnormal fetal growth. Prof. Wu has authored 70 peer-reviewed papers in international journals such as EBioMedicine, Clinical Epigenetics, Environment International, Toxicological Sciences, Scientific Reports, Human Reproduction, and Molecular Human Reproduction.

Dr. Sherief Abd-Elsalam did M.S. in Tropical Medicine and Infectious diseases from the Faculty of Medicine, Tanta University, Egypt in 2007. He obtained his PhD in Tropical Medicine and Infectious diseases from the Faculty of Medicine, Tanta University, Egypt in 2013. He is currently working as an Assistant Professor of Tropical Medicine and Infectious diseases department – Tanta University Faculty of Medicine, Egypt.

Dr. Alexander E. Berezin has received PhD in 1994 in the State Medical University of Zaporozhye (Ukraine). He is currently working as a Professor of Medicine in the State Medical University of Zaporozhye (Ukraine). His research goals are fundamental study of biological markers, the development of cardiovascular prevention and rehabilitation. Based on this research and training in heart failure he has received several awards and honors. He has published 850 papers and more in reputed journals, 27 books/chapters and has been serving as an editorial board member of repute.

Dr. Ricardo David Couto graduated in Pharmacy (1998) and he also obtained a Master’s degree and Ph.D. in Pharmacy (Clinical Analysis) degree from University of São Paulo (2000 - 2005). He is currently working as an Associate Professor III position at UFBA. He has a vast experience in the area of Laboratory Diagnosis of Diseases, with emphasis on validation and development of diagnostic tests, lipoproteins, human and experimental atherosclerosis. His areas of expertise are Health Sciences and particularly Pharmacy (subareas are lipídios, lipoproteínas e aterosclerose experimental). Dr. Couto has published around 50 articles in Scientific Journals so far.

Dr. Khalid El Bairi is affiliated with Mohammed 1st University is currently affiliated with Faculty of Medicine and Pharmacy, Cancer Biomarkers Working Group, Gynecologic Oncology and Cancer Biology, Oujda, Oriental, Morocco. His research work is a part of the scientific activities of recently launched Cancer Biomarkers Working Group (which focuses on various areas in cancer biomarkers covering TILs, genomic signatures, and proteomic markers). He has around 10 selected publications to his credit so far.

Dr. Matthias Hamdorf obtained his Ph.D. degree (Dr. phil. nat.) magna cum laude in 2007 from Paul Ehrlich Institute (Division of Medical Biotechnology), Langen, Germany. Since Feb 2016, Dr. Hamdorf is Research Scientist (PI) at Terasaki Research Institute, Los Angeles, CA, USA. His research and development focus is on Virology, (Retroviruses, Lentiviruses, viral vectors and Poxviruses), Cell signaling (host-virus interaction, signaling during differentiation, Cytokine signaling), Cancer research (liver, lung and melanoma), Human iPS and hematopoietic stem cells (reprogramming and differentiation), miRNA and siRNA (screening of libraries, retroviral expression of miRs/anti-miRs, target prediction), etc. Dr. Hamdorf, as an author/co-author, has published more than 15 articles in various journals, having over 525 total citations.

Dr. Chen is a pioneer in identifying biomarkers in distal body fluid of lung cancer patients by taking advantages of genetically engineered mouse model. One important goal of his lab is to predict the genotyping of the lung cancer by the biomarker information identified in patients’ urine. His research interest extends into precision medicine and driving molecular events underlying lung cancer tumorigenesis.

Dr. Biswaranjan Paital is presently serving as an Assistant Professor of Zoology at CBSH, Orissa University of Agriculture and Technology. He obtained PhD in Zoology in 2010 from Utkal University, Bhubaneswar, Odisha,India. He is an Editorial member of different journals such as Journal of Environmental and Occupational Science, Research journal of Biology, American Journal of Life Sciences, and many other journals. He has contributed his valuable publications in different journals. He is also a reviewer in Scopus/PubMed Listed International Journals. He also attended National and International conferences.

Katarzyna Rygiel, MD, PhD, has a background in primary care and research/education. She is a graduate of the Medical University of Silesia (SUM) in Katowice, Poland, and she holds a certificate in Clinical Trials Design and Management from University of California, San Diego in La Jolla, USA, where she completed her research training. Her research interests and publications include current topics in cardio-oncology (especially in patients with breast cancer), biomarkers (e.g., in various oncology and cardiology aspects), interdisciplinary patient-centered approaches, especially in patients with chronic psychosomatic diseases, receiving polytherapy. She promotes the integration of lifestyle modifications and stress management with medically necessary treatments.

Amit Kumar Srivastava earned his Bachelor’s in Pharmacy (2010) from Bharat Institute of Technology, Meerut, India and Master’s in Pharmacology (2013) from Truba Institute of Pharmacy, Bhopal, India. His research interest focuses on the development of novel strategies for the diagnosis, treatment and prevention of infectious and autoimmune diseases. He has expertise in conducting in vivo studies of the drug molecules in the early preclinical development phase. He has authored 33 scientific publications in peer-reviewed scientific journals and also serving as an editorial board member and peer reviewer in scientific journals of repute. He is a member of many learned societies including The Biotech Research Society, India and The Indian Science Congress Association, India.

Dr. Nikolina Tzvekova is currently working as Professor of Plant Physiology in the Faculty of Forestry at University of Forestry, Sofia, Bulgaria. Her skills and expertise mainly lie in the subject areas/fields of Environmental Impact Assessment, Sustainable Development, Plant Physiology, Plant Ecology, Environmental Science, Climate Change Adaptation, Heavy Metals, Forestry, Photosynthesis, Reforestation, Phytoremediation, Phenology, etc. Dr. Tzvekova, as an author/co-author, has published over 20 manuscripts in various journals.

Dr. Dmitry A. Verbenko obtained his Ph.D. degree (in 2008) in Genetics and Molecular Genetics from the Institute of Molecular Genetics (Russian Academy of Sciences), Department of Molecular Bases of Human Genetics, Moscow, Russia. Presently, Dr. Verbenko is employed as Senior Researcher, STD and Dermatoses Department at State Research Center for Dermatovenereology and Cosmetology (Ministry of Health of Russian Federation), Moscow, Russia. His skills and expertise mainly lie in the subject areas/fields of PCR, Molecular Genetics, Molecular Diagnostics, Human Evolutionary Genetics, Gene Expression Analysis, etc. Dr. Verbenko, as an author/co-author, has published over 15 manuscripts in various journals of international repute.

Prof. Dr. XIAOFENG DAI is presently serving as a Professor, Theme Leader – Cancer Biology and Biomarker Discovery at Jiangnan University, China. She completed her Master of Science from University of Tampere (Finland) and she further obtained PhD in 2010 from University of Tampere (Finland). She has contributed her publications in different journals, having citations around 500. She has also been recognized with many awards such as Young Doctor Award,Best Scholar Award in JiangNan University and Chinese Government Award for Outstanding Self-financed Students Abroad and many other awards.

Dr. Alexander E. Berezin has received PhD in 1994 in the State Medical University of Zaporozhye (Ukraine). He is currently working as a Professor of Medicine in the State Medical University of Zaporozhye (Ukraine). His research goals are fundamental study of biological markers, the development of cardiovascular prevention and rehabilitation. Based on this research and training in heart failure he has received several awards and honors. He has published 850 papers and more in reputed journals, 27 books/chapters and has been serving as an editorial board member of repute.